Evidence map›Paper›PMID 42538375›Full record

ArticleNpj viruses2026

Side-by-side evaluation of two Crimean-Congo hemorrhagic fever virus isolates in IFNAR

Cornelius Rohde, Anke-Dorothee Werner, Michelle Gellhorn Serra, Petra Emmerich, Nataša Knap, Markus Eickmann, Stephan Becker, Verena Krähling, Alexandra Kupke, BSL4 Animal Facility Team

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Npj viruses, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Cornelius RohdePhilipps-Universität Marburg, Marburg, Fachbereich Medizin, Institut für Virologie, Marburg, Germany.
Anke-Dorothee WernerPhilipps-Universität Marburg, Marburg, Fachbereich Medizin, Institut für Virologie, Marburg, Germany.
Michelle Gellhorn SerraPhilipps-Universität Marburg, Marburg, Fachbereich Medizin, Institut für Virologie, Marburg, Germany.
Petra EmmerichDepartment of Virology, Bernhard Nocht Institute of Tropical Medicine, Hamburg, Germany.
Nataša KnapInstitute of Microbiology and Immunology, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.
Markus EickmannPhilipps-Universität Marburg, Marburg, Fachbereich Medizin, Institut für Virologie, Marburg, Germany.
Stephan BeckerPhilipps-Universität Marburg, Marburg, Fachbereich Medizin, Institut für Virologie, Marburg, Germany.
Verena KrählingPhilipps-Universität Marburg, Marburg, Fachbereich Medizin, Institut für Virologie, Marburg, Germany.
Alexandra KupkePhilipps-Universität Marburg, Marburg, Fachbereich Medizin, Institut für Virologie, Marburg, Germany. kupke@staff.uni-marburg.de.
BSL4 Animal Facility Team

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Crimean-Congo hemorrhagic fever virus (CCHFV) is the causative agent of a severe hemorrhagic fever in humans, associated with case fatality rates up to 40%. Due to the lack of approved vaccines or specific antiviral treatments, CCHFV is classified as a biosafety level 4 (BSL4) pathogen in most countries and designated a priority pathogen by the World Health Organization. To facilitate the preclinical assessment of medical countermeasures, we have established a murine model using C57BL/6J IFNAR

Identifiers

PMID42538375
PMCPMC13427833

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.